Skip to main content
Equibles

JPMORGAN CHASE & CO

Position in FLNA — Filana Therapeutics, Inc.

CIK 19617 NEW YORK, NY
Back to FLNA Full portfolio

Position in FLNA

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$20,269
+$20,248 QoQ
Shares Held
17,033
+130923.1% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 84 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FLNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,254,031 across 424 Biotechnology names. FLNA ranks #327 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,517,600 $3,237,487,438
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,774,199 $2,353,364,036
3 INSM
INSMED Inc
 10,428,170 $1,111,851,478
4 ALNY
Alnylam Pharmaceuticals, Inc.
 2,675,517 $805,410,876
5 RVMD
Revolution Medicines, Inc.
 3,298,066 $617,661,794
6 RYTM
Rhythm Pharmaceuticals, Inc.
 2,652,746 $294,534,385
7 JAZZ
Jazz Pharmaceuticals plc
 1,160,786 $279,714,596
8 QURE
uniQure N.V.
 4,867,755 $224,208,791

All Filings in FLNA

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,269 17,033
2026-03-31 $21 13
2025-12-31 $25 13
2025-09-30 $1,645,426 565,439
2025-06-30 $1,370,279 757,061
2025-03-31 $1,185,023 790,016
2024-12-31 $947,149 401,335
2024-09-30 $1,069,868 36,353
2024-06-30 $690,079 55,877
2024-03-31 $1,133,680 55,874
2023-12-31 $1,240,953 55,129
2023-09-30 $818,737 49,203
2023-06-30 $1,363,801 55,620
2023-03-31 $1,196,520 49,607
2022-12-31 $1,162,841 39,365
2022-09-30 $1,468,968 35,126
2022-06-30 $1,570,950 55,866
2022-03-31 $1,066,586 28,718
2021-12-31 $1,074,800 24,595
2021-09-30 $1,430,880 23,049
2021-06-30 $2,209,221 25,857
2021-03-31 $2,186,053 48,633
2020-12-31 $98,964 14,511
2020-09-30 $99,446 8,640
2020-06-30 $24,008 7,795